Cognetivity Neurosciences Ltd. Share Price

Stocks

CGNS.F

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Delayed OTC Markets 01:20:56 30/05/2026 am IST 5-day change 1st Jan Change
0.000100 USD +9,900.00% Intraday chart for Cognetivity Neurosciences Ltd. -.--% +9,900.00%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 11.99L 9L 7L 7L 6L 8.1Cr 12.11L 80.41L 31.41L 3.97Cr 32.18L 31.5L 14Cr P/E Ratio 2022
-2.9x
P/E Ratio 2023 -2.8x
Enterprise Value 2L 2L 2L 1L 1L 1.66Cr 2L 16.45L 6L 81.18L 7L 6L 2.81Cr EV / Sales 2022
-
EV / Sales 2023 43,79,22,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.23
5 years 0
Extreme 0
1.12
10 years 0
Extreme 0
1.12
Manager TitleAgeSince
Chief Executive Officer 45 01/04/2013
Compliance Officer 67 21/12/2017
Director TitleAgeSince
Director/Board Member 45 01/01/2017
Director/Board Member 67 21/12/2017
Date Insider Type Main position Quantity % Market Cap.
15/24/15Option

Founder

6,00,000 0.6697%
15/24/15Option

Founder

6,00,000 0.6697%
23/23/23Sell

Founder

11,08,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-99.96% 9.36T
+2.17%-2.52%-42.72%-19.02% 2.59TCr
+0.34%-0.66%-39.17%+154.09% 1.21TCr
-3.25%-3.44%-8.00%+52.51% 619.14Cr
-0.12%+16.99% - - 286.66Cr
+4.97%-5.49%+35.68%-45.18% 172.05Cr
+8.36%+5.16% - - 158.7Cr
0.00%-4.31%-33.27%-59.89% 81Cr
-2.36%-0.65%-29.51%+205.40% 80Cr
-1.76%-1.36%-36.05%-41.12% 72Cr
Average +991.01%-0.80%-19.13%+18.35% 527.06Cr
Weighted average by Cap. +1.30%-3.18%-34.10%+35.29%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.07 0.05 0.3 0.12 1.5 0.12 0.12 5.2
Net income -1.31Cr -93.91L -80.94L -74.49L -69.88L -89Cr -1.33Cr -8.81Cr -3.44Cr -43Cr -3.52Cr -3.45Cr -150.4Cr -74.34L -53.18L -45.84L -42.19L -39.57L -50Cr -75.08L -4.99Cr -1.95Cr -25Cr -2Cr -1.95Cr -85Cr
Net Debt -82.43T -58.97T -50.83T -46.78T -43.88T -55.73L -83.25T -6L -2L -27.29L -2L -2L -94.44L -10L -7L -6L -5L -5L -6.45Cr -10L -63.96L -24.98L -3.16Cr -25.6L -25.05L -11Cr
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGNS.F Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!